Suvoda and Greenphire Announce Completion of Merger

Suvoda and Greenphire have successfully completed their merger, creating a combined company named Suvoda that will provide comprehensive clinical trial technology solutions. The merger brings together Suvoda's expertise in randomization, trial supply management, and patient outcomes data collection with Greenphire's leadership in clinical trial payments, financial management, and patient support tools. The combined company will be led by Jagath Wanninayake, Suvoda's Founder and CEO, with Thoma Bravo as the lead strategic investor, and Bain Capital Tech Opportunities Fund and LLR Partners making significant minority investments.